機能サービスプロバイダの世界市場調査レポート-2030年までの予測

Global Functional Service Providers Market Research Report - Forecast to 2030

機能サービスプロバイダの世界市場調査レポート-2030年までの予測市場概要機能的サービスプロバイダ（FSP）市場は、レビュー期間中に7.49％の健全なCAGRを記録すると予測されている。この市場を牽引して... もっと見る

出版社	出版年月	電子版価格	ページ数	言語
Market Research Future マーケットリサーチフューチャー (MRFR)	2023年10月18日	US$7,250 ライセンス・価格情報注文方法はこちら	141	英語

目次
図表リスト

サマリー

機能サービスプロバイダの世界市場調査レポート-2030年までの予測

市場概要
機能的サービスプロバイダ（FSP）市場は、レビュー期間中に7.49％の健全なCAGRを記録すると予測されている。この市場を牽引しているのは、研究開発思惑の拡大、臨床前段階の増加、医薬品改良におけるFSP再考の高まりなど、いくつかの変数である。
特にバイオ医薬品とバイオテクノロジー企業における研究開発ベンチャーの増加により、世界市場で機能的サービスプロバイダー（FSP）の需要が高まっている。調査によると、巨大バイオ医薬品企業によるFSPの利用は、年間13％以上のペースで拡大している。これらのサービス・プロバイダーは、バイオ医薬品やバイオテクノロジー企業の研究開発プロジェクトにスタッフを派遣している。彼らは、非常に優秀な研究パートナー、情報管理者、集中オーガナイザー、臨床スクリーニング、およびその他の関連スタッフをこれらの組織に提供します。バイオ医薬品やバイオテクノロジー企業は、絶え間ない探索を中心に、新しい進歩やサイクルの創造と導入に取り組んでいる。
さらに、FSPは、予備管理、臨床観察、インフォメーション・ザ・ボード、測定可能なプログラミング、生物統計学、臨床構成、ライフサイクル・セキュリティ、管理業務などのアレンジメントを提供する。臨床前段階の面倒で費用のかかる性質と、高い責任がもたらす問題が、FSPの名声を高めている。これらのプロバイダーは組織の時間を節約し、機能的経費を軽減する。
市場区分
世界の機能的サービス・サプライヤー市場は、臨床チェック、臨床構成、インフォメーション・ザ・ボード、ファーマコビジランス、生物統計/プログラミング、管理業務、その他にタイプ別に分けられる。

ステージの観点からは、世界の機能的サービス供給者市場は臨床転機と承認後に分類されます。用途別では、世界市場はバイオ医薬品企業、バイオテクノロジー企業、臨床機器企業、試験機関および学術機関に分類される。
地域別洞察
北米の機能的サービスプロバイダー市場は、2022年に約41%の割合を占め、最大の市場を形成した。その理由は、医療基盤が構築され、臨床前段階が無数にあり、IQVIA（米国）、Parexel（米国）、Labcorp Medication Improvement（米国）のような重要な参加者がこの地域に存在するためである。カナダで臨床前臨床試験を承認しているウェルビーイング・カナダによると、カナダでは約900の臨床前臨床試験が一貫して登録されている。
欧州の機能的サービス・サプライヤー市場は、技術革新の進展、医療利用の拡大、進行中の病気の蔓延拡大により、パイの2番目に大きな部分を占めている。
アジア太平洋地域の機能的サービス・プロバイダー市場は、2023年から2032年にかけて最も急速に成長すると予想されている。また、ファンクショナル・サービス・プロバイダー（FSP）市場の中心的な参加企業は、アジア太平洋地域に効果的に進出している。
主要企業
ファンクショナル・サービス・プロバイダー市場の主要企業は、Parexel International Corporation（米国）、IQVIA, Inc.（米国）、Quanticate International Limited（英国）、KPS Life, LLC（米国）、Rho, Inc.（米国）、Laboratory Corporation of America Holdings（米国）、BioPoint Inc.（米国）、Icon Plc（アイルランド）、Wuxi Apptec co.(Ltd.（中国）、PPD Inc.）

ページTOPに戻る

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

2 MARKET INTRODUCTION

2.1 DEFINITION

2.2 SCOPE OF THE STUDY

2.3 RESEARCH OBJECTIVE

2.4 MARKET STRUCTURE

2.5 ASSUMPTIONS & LIMITATIONS

3 RESEARCH METHODOLOGY

3.1 DATA MINING

3.2 SECONDARY RESEARCH

3.3 PRIMARY RESEARCH

3.4 BREAKDOWN OF PRIMARY RESPONDENTS

3.5 FORECASTING TECHNIQUES

3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION

3.6.1 BOTTOM-UP APPROACH

3.6.2 TOP-DOWN APPROACH

3.7 DATA TRIANGULATION

3.8 VALIDATION

4 MARKET DYNAMICS

4.1 OVERVIEW

4.2 DRIVERS

4.2.1 INCREASING R&D INVESTMENTS

4.2.2 RISING NUMBER OF CLINICAL TRIALS

4.2.3 LOWERED OPERATIONAL COSTS AND IMPROVED SERVICE QUALITY

4.2.4 RISE IN FSP OUTSOURCING IN DRUG DEVELOPMENT

4.3 RESTRAINTS

4.3.1 DEARTH OF SKILLED LABOR

4.4 OPPORTUNITIES

4.4.1 BIOPHARMA AND BIOTECH’S DIGITAL TRANSFORMATION

5 MARKET FACTOR ANALYSIS

5.1 VALUE CHAIN ANALYSIS

5.1.1 CUSTOMER ACQUISITION (PREPURCHASE QUERY)

5.1.2 SERVICE CUSTOMIZATION

5.1.3 CUSTOMER PURCHASE SUPPORT

5.1.4 CUSTOMER FULFILMENT & POST-PURCHASE SUPPORT

5.2 PORTER'S FIVE FORCES MODEL

5.2.1 THREAT OF NEW ENTRANTS

5.2.2 BARGAINING POWER OF SUPPLIERS

5.2.3 THREAT OF SUBSTITUTES

5.2.4 BARGAINING POWER OF BUYERS

5.2.5 INTENSITY OF RIVALRY

5.3 IMPACT OF COVID-19 ON FUNCTIONAL SERVICE PROVIDERS MARKET

5.3.1 OVERVIEW

5.3.2 IMPACT ON DEMAND FOR FUNCTIONAL SERVICE PROVIDERS (FSP)

6 GLOBAL FUNCTIONAL SERVICE PROVIDERS MARKET BY TYPE

6.1 OVERVIEW

6.2 CLINICAL MONITORING

6.3 MEDICAL WRITING

6.4 DATA MANAGEMENT

6.5 PHARMACOVIGILANCE

6.6 BIOSTATISTICS/PROGRAMMING

6.7 REGULATORY AFFAIRS

6.8 OTHERS

7 GLOBAL FUNCTIONAL SERVICE PROVIDERS MARKET BY STAGE

7.1 OVERVIEW

7.2 CLINICAL DEVELOPMENT

7.3 POST APPROVAL

8 GLOBAL FUNCTIONAL SERVICE PROVIDERS MARKET BY APPLICATION

8.1 OVERVIEW

8.2 BIOPHARMA COMPANIES

8.3 BIOTECH COMPANIES

8.4 MEDICAL DEVICES COMPANIES

8.5 RESEARCH CENTER AND ACADEMIC INSTITUTES

9 GLOBAL FUNCTIONAL SERVICE PROVIDERS MARKET, BY REGION

9.1 OVERVIEW

9.2 NORTH AMERICA

9.2.1 US

9.2.2 CANADA

9.3 EUROPE

9.3.1 GERMANY

9.3.2 UK

9.3.3 FRANCE

9.3.4 ITALY

9.3.5 SPAIN

9.3.6 REST OF EUROPE

9.4 ASIA PACIFIC

9.4.1 CHINA

9.4.2 JAPAN

9.4.3 INDIA

9.4.4 AUSTRALIA

9.4.5 SOUTH KOREA

9.4.6 REST OF ASIA-PACIFIC

9.5 REST OF THE WORLD

9.5.1 LATIN AMERICA

9.5.2 MIDDLE EAST

9.5.3 AFRICA

10 COMPETITIVE LANDSCAPE

10.1 OVERVIEW

10.2 COMPETITIVE BENCHMARKING

10.3 MAJOR GROWTH STRATEGY IN THE GLOBAL FUNCTIONAL SERVICE PROVIDERS MARKET

10.4 THE LEADING PLAYERS IN TERMS OF NUMBER OF DEVELOPMENTS IN THE GLOBAL FUNCTIONAL SERVICE PROVIDERS MARKET

10.5 KEY DEVELOPMENT ANALYSIS

10.6 KEY DEVELOPMENTS & GROWTH STRATEGIES

10.6.1 PRODUCT LAUNCHES

10.6.2 PARTNERSHIPS

10.6.3 ACQUISITIONS

10.7 MAJOR PLAYERS FINANCIAL MATRIX

10.7.1 SALES (USD MILLION), 2022

10.7.2 RESEARCH & DEVELOPMENT EXPENDITURE (USD MILLION), 2022

11 COMPANY PROFILES

11.1 IQVIA INC.

11.1.1 COMPANY OVERVIEW

11.1.2 FINANCIAL OVERVIEW

11.1.3 SOLUTIONS/SERVICES OFFERED

11.1.4 KEY DEVELOPMENTS

11.1.5 SWOT ANALYSIS

11.1.6 KEY STRATEGIES

11.2 LABORATORY CORPORATION OF AMERICA HOLDINGS

11.2.1 COMPANY OVERVIEW

11.2.2 FINANCIAL OVERVIEW

11.2.3 PRODUCTS/SERVICES OFFERED

11.2.4 KEY DEVELOPMENTS

11.2.5 SWOT ANALYSIS

11.2.6 KEY STRATEGIES

11.3 ICON PLC

11.3.1 COMPANY OVERVIEW

11.3.2 FINANCIAL OVERVIEW

11.3.3 PRODUCTS/SERVICES OFFERED

11.3.4 KEY DEVELOPMENTS

11.3.5 SWOT ANALYSIS

11.3.6 KEY STRATEGIES

11.4 KPS LIFE, LLC

11.4.1 COMPANY OVERVIEW

11.4.2 FINANCIAL OVERVIEW

11.4.3 PRODUCTS/SERVICES OFFERED

11.4.4 KEY DEVELOPMENTS

11.4.5 KEY STRATEGIES

11.5 WUXI APPTEC CO., LTD.

11.5.1 COMPANY OVERVIEW

11.5.2 FINANCIAL OVERVIEW

11.5.3 SOLUTIONS/SERVICES OFFERED

11.5.4 KEY DEVELOPMENTS

11.5.5 SWOT ANALYSIS

11.5.6 KEY STRATEGIES

11.6 PPD INC.

11.6.1 COMPANY OVERVIEW

11.6.2 FINANCIAL OVERVIEW

11.6.3 SOLUTIONS/SERVICES OFFERED

11.6.4 KEY DEVELOPMENTS

11.6.5 KEY STRATEGIES

11.7 PAREXEL INTERNATIONAL CORPORATION

11.7.1 COMPANY OVERVIEW

11.7.2 FINANCIAL OVERVIEW

11.7.3 PRODUCTS/SERVICES OFFERED

11.7.4 KEY DEVELOPMENTS

11.7.5 KEY STRATEGIES

11.8 QUANTICATE INTERNATIONAL LIMITED

11.8.1 COMPANY OVERVIEW

11.8.2 FINANCIAL OVERVIEW

11.8.3 PRODUCTS/SERVICES OFFERED

11.8.4 KEY DEVELOPMENTS

11.8.5 KEY STRATEGIES

11.9 BIOPOINT INC.

11.9.1 COMPANY OVERVIEW

11.9.2 FINANCIAL OVERVIEW

11.9.3 PRODUCTS/SERVICES OFFERED

11.9.4 KEY DEVELOPMENTS

11.9.5 KEY STRATEGIES

11.10 RHO, INC.

11.10.1 COMPANY OVERVIEW

11.10.2 FINANCIAL OVERVIEW

11.10.3 PRODUCTS/SERVICES OFFERED

11.10.4 KEY DEVELOPMENTS

11.10.5 KEY STRATEGIES

12 APPENDIX

12.1 REFERENCES

12.2 RELATED REPORTS

ページTOPに戻る

図表リスト

LIST OF TABLES

TABLE 1 LIST OF ASSUMPTIONS & LIMITATIONS

TABLE 2 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS

TABLE 3 GLOBAL: FUNCTIONAL SERVICE PROVIDERS MARKET, BY TYPE, 2019-2030 (USD MILLION)

TABLE 4 GLOBAL: FUNCTIONAL SERVICE PROVIDERS MARKET, FOR CLINICAL MONITORING, BY REGION, 2019–2030 (USD MILLION)

TABLE 5 GLOBAL: FUNCTIONAL SERVICE PROVIDERS MARKET, FOR MEDICAL WRITING, BY REGION, 2019–2030 (USD MILLION)

TABLE 6 GLOBAL: FUNCTIONAL SERVICE PROVIDERS MARKET, FOR DATA MANAGEMENT, BY REGION, 2019–2030 (USD MILLION)

TABLE 7 GLOBAL: FUNCTIONAL SERVICE PROVIDERS MARKET, FOR PHARMACOVIGILANCE, BY REGION, 2019–2030 (USD MILLION)

TABLE 8 GLOBAL: FUNCTIONAL SERVICE PROVIDERS MARKET, FOR BIOSTATISTICS/PROGRAMMING, BY REGION, 2019–2030 (USD MILLION)

TABLE 9 GLOBAL: FUNCTIONAL SERVICE PROVIDERS MARKET, FOR REGULATORY AFFAIRS, BY REGION, 2019–2030 (USD MILLION)

TABLE 10 GLOBAL: FUNCTIONAL SERVICE PROVIDERS MARKET, FOR OTHERS, BY REGION, 2019–2030 (USD MILLION)

TABLE 11 GLOBAL: FUNCTIONAL SERVICE PROVIDERS MARKET, BY STAGE, 2019-2030 (USD MILLION)

TABLE 12 GLOBAL: FUNCTIONAL SERVICE PROVIDERS MARKET, FOR CLINICAL DEVELOPMENT, BY REGION, 2019–2030 (USD MILLION)

TABLE 13 GLOBAL: FUNCTIONAL SERVICE PROVIDERS MARKET, FOR POST APPROVAL, BY REGION, 2019–2030 (USD MILLION)

TABLE 14 GLOBAL: FUNCTIONAL SERVICE PROVIDERS MARKET, BY APPLICATION, 2019-2030 (USD MILLION)

TABLE 15 GLOBAL: FUNCTIONAL SERVICE PROVIDERS MARKET, FOR BIOPHARMA COMPANIES, BY REGION, 2019–2030 (USD MILLION)

TABLE 16 GLOBAL: FUNCTIONAL SERVICE PROVIDERS MARKET, FOR BIOTECH COMPANIES, BY REGION, 2019–2030 (USD MILLION)

TABLE 17 GLOBAL: FUNCTIONAL SERVICE PROVIDERS MARKET, FOR MEDICAL DEVICES COMPANIES, BY REGION, 2019–2030 (USD MILLION)

TABLE 18 GLOBAL: FUNCTIONAL SERVICE PROVIDERS MARKET, FOR RESEARCH CENTER AND ACADEMIC INSTITUTES, BY REGION, 2019–2030 (USD MILLION)

TABLE 19 GLOBAL: FUNCTIONAL SERVICE PROVIDERS MARKET, BY REGION, 2019–2030 (USD MILLION)

TABLE 20 NORTH AMERICA: FUNCTIONAL SERVICE PROVIDERS MARKET, BY COUNTRY, 2019–2030 (USD MILLION)

TABLE 21 NORTH AMERICA: FUNCTIONAL SERVICE PROVIDERS MARKET, BY TYPE, 2019–2030 (USD MILLION)

TABLE 22 NORTH AMERICA: FUNCTIONAL SERVICE PROVIDERS MARKET, BY STAGE, 2019–2030 (USD MILLION)

TABLE 23 NORTH AMERICA: FUNCTIONAL SERVICE PROVIDERS MARKET, BY APPLICATION, 2019–2030 (USD MILLION)

TABLE 24 US: FUNCTIONAL SERVICE PROVIDERS MARKET, BY TYPE, 2019–2030 (USD MILLION)

TABLE 25 US: FUNCTIONAL SERVICE PROVIDERS MARKET, BY STAGE, 2019–2030 (USD MILLION)

TABLE 26 US: FUNCTIONAL SERVICE PROVIDERS MARKET, BY APPLICATION, 2019–2030 (USD MILLION)

TABLE 27 CANADA: FUNCTIONAL SERVICE PROVIDERS MARKET, BY TYPE, 2019–2030 (USD MILLION)

TABLE 28 CANADA: FUNCTIONAL SERVICE PROVIDERS MARKET, BY STAGE, 2019–2030 (USD MILLION)

TABLE 29 CANADA: FUNCTIONAL SERVICE PROVIDERS MARKET, BY APPLICATION, 2019–2030 (USD MILLION)

TABLE 30 EUROPE: FUNCTIONAL SERVICE PROVIDERS MARKET, BY COUNTRY, 2019–2030 (USD MILLION)

TABLE 31 EUROPE: FUNCTIONAL SERVICE PROVIDERS MARKET, BY TYPE, 2019–2030 (USD MILLION)

TABLE 32 EUROPE: FUNCTIONAL SERVICE PROVIDERS MARKET, BY STAGE, 2019–2030 (USD MILLION)

TABLE 33 EUROPE: FUNCTIONAL SERVICE PROVIDERS MARKET, BY APPLICATION, 2019–2030 (USD MILLION)

TABLE 34 GERMANY: FUNCTIONAL SERVICE PROVIDERS MARKET, BY TYPE, 2019–2030 (USD MILLION)

TABLE 35 GERMANY: FUNCTIONAL SERVICE PROVIDERS MARKET, BY STAGE, 2019–2030 (USD MILLION)

TABLE 36 GERMANY: FUNCTIONAL SERVICE PROVIDERS MARKET, BY APPLICATION, 2019–2030 (USD MILLION)

TABLE 37 UK: FUNCTIONAL SERVICE PROVIDERS MARKET, BY TYPE, 2019–2030 (USD MILLION)

TABLE 38 UK: FUNCTIONAL SERVICE PROVIDERS MARKET, BY STAGE, 2019–2030 (USD MILLION)

TABLE 39 UK: FUNCTIONAL SERVICE PROVIDERS MARKET, BY APPLICATION, 2019–2030 (USD MILLION)

TABLE 40 FRANCE: FUNCTIONAL SERVICE PROVIDERS MARKET, BY TYPE, 2019–2030 (USD MILLION)

TABLE 41 FRANCE: FUNCTIONAL SERVICE PROVIDERS MARKET, BY STAGE, 2019–2030 (USD MILLION)

TABLE 42 FRANCE: FUNCTIONAL SERVICE PROVIDERS MARKET, BY APPLICATION, 2019–2030 (USD MILLION)

TABLE 43 ITALY: FUNCTIONAL SERVICE PROVIDERS MARKET, BY TYPE, 2019–2030 (USD MILLION)

TABLE 44 ITALY: FUNCTIONAL SERVICE PROVIDERS MARKET, BY STAGE, 2019–2030 (USD MILLION)

TABLE 45 ITALY: FUNCTIONAL SERVICE PROVIDERS MARKET, BY APPLICATION, 2019–2030 (USD MILLION)

TABLE 46 SPAIN: FUNCTIONAL SERVICE PROVIDERS MARKET, BY TYPE, 2019–2030 (USD MILLION)

TABLE 47 SPAIN: FUNCTIONAL SERVICE PROVIDERS MARKET, BY STAGE, 2019–2030 (USD MILLION)

TABLE 48 SPAIN: FUNCTIONAL SERVICE PROVIDERS MARKET, BY APPLICATION, 2019–2030 (USD MILLION)

TABLE 49 REST OF EUROPE: FUNCTIONAL SERVICE PROVIDERS MARKET, BY TYPE, 2019–2030 (USD MILLION)

TABLE 50 REST OF EUROPE: FUNCTIONAL SERVICE PROVIDERS MARKET, BY STAGE, 2019–2030 (USD MILLION)

TABLE 51 REST OF EUROPE: FUNCTIONAL SERVICE PROVIDERS MARKET, BY APPLICATION, 2019–2030 (USD MILLION)

TABLE 52 ASIA-PACIFIC: FUNCTIONAL SERVICE PROVIDERS MARKET, BY COUNTRY, 2019–2030 (USD MILLION)

TABLE 53 ASIA-PACIFIC: FUNCTIONAL SERVICE PROVIDERS MARKET, BY TYPE, 2019–2030 (USD MILLION)

TABLE 54 ASIA-PACIFIC: FUNCTIONAL SERVICE PROVIDERS MARKET, BY STAGE, 2019–2030 (USD MILLION)

TABLE 55 ASIA-PACIFIC: FUNCTIONAL SERVICE PROVIDERS MARKET, BY APPLICATION, 2019–2030 (USD MILLION)

TABLE 56 CHINA: FUNCTIONAL SERVICE PROVIDERS MARKET, BY TYPE, 2019–2030 (USD MILLION)

TABLE 57 CHINA: FUNCTIONAL SERVICE PROVIDERS MARKET, BY STAGE, 2019–2030 (USD MILLION)

TABLE 58 CHINA: FUNCTIONAL SERVICE PROVIDERS MARKET, BY APPLICATION, 2019–2030 (USD MILLION)

TABLE 59 JAPAN: FUNCTIONAL SERVICE PROVIDERS MARKET, BY TYPE, 2019–2030 (USD MILLION)

TABLE 60 JAPAN: FUNCTIONAL SERVICE PROVIDERS MARKET, BY STAGE, 2019–2030 (USD MILLION)

TABLE 61 JAPAN: FUNCTIONAL SERVICE PROVIDERS MARKET, BY APPLICATION, 2019–2030 (USD MILLION)

TABLE 62 INDIA: FUNCTIONAL SERVICE PROVIDERS MARKET, BY TYPE, 2019–2030 (USD MILLION)

TABLE 63 INDIA: FUNCTIONAL SERVICE PROVIDERS MARKET, BY STAGE, 2019–2030 (USD MILLION)

TABLE 64 INDIA: FUNCTIONAL SERVICE PROVIDERS MARKET, BY APPLICATION, 2019–2030 (USD MILLION)

TABLE 65 AUSTRALIA: FUNCTIONAL SERVICE PROVIDERS MARKET, BY TYPE, 2019–2030 (USD MILLION)

TABLE 66 AUSTRALIA: FUNCTIONAL SERVICE PROVIDERS MARKET, BY STAGE, 2019–2030 (USD MILLION)

TABLE 67 AUSTRALIA: FUNCTIONAL SERVICE PROVIDERS MARKET, BY APPLICATION, 2019–2030 (USD MILLION)

TABLE 68 SOUTH KOREA: FUNCTIONAL SERVICE PROVIDERS MARKET, BY TYPE, 2019–2030 (USD MILLION)

TABLE 69 SOUTH KOREA: FUNCTIONAL SERVICE PROVIDERS MARKET, BY STAGE, 2019–2030 (USD MILLION)

TABLE 70 SOUTH KOREA: FUNCTIONAL SERVICE PROVIDERS MARKET, BY APPLICATION, 2019–2030 (USD MILLION)

TABLE 71 REST OF ASIA-PACIFIC: FUNCTIONAL SERVICE PROVIDERS MARKET, BY TYPE, 2019–2030 (USD MILLION)

TABLE 72 REST OF ASIA-PACIFIC: FUNCTIONAL SERVICE PROVIDERS MARKET, BY STAGE, 2019–2030 (USD MILLION)

TABLE 73 REST OF ASIA-PACIFIC: FUNCTIONAL SERVICE PROVIDERS MARKET, BY APPLICATION, 2019–2030 (USD MILLION)

TABLE 74 REST OF THE WORLD: FUNCTIONAL SERVICE PROVIDERS MARKET, BY REGION, 2019–2030 (USD MILLION)

TABLE 75 REST OF THE WORLD: FUNCTIONAL SERVICE PROVIDERS MARKET, BY TYPE, 2019–2030 (USD MILLION)

TABLE 76 REST OF THE WORLD: FUNCTIONAL SERVICE PROVIDERS MARKET, BY STAGE, 2019–2030 (USD MILLION)

TABLE 77 REST OF THE WORLD: FUNCTIONAL SERVICE PROVIDERS MARKET, BY APPLICATION, 2019–2030 (USD MILLION)

TABLE 78 LATIN AMERICA: FUNCTIONAL SERVICE PROVIDERS MARKET, BY TYPE, 2019–2030 (USD MILLION)

TABLE 79 LATIN AMERICA: FUNCTIONAL SERVICE PROVIDERS MARKET, BY STAGE, 2019–2030 (USD MILLION)

TABLE 80 LATIN AMERICA: FUNCTIONAL SERVICE PROVIDERS MARKET, BY APPLICATION, 2019–2030 (USD MILLION)

TABLE 81 MIDDLE EAST: FUNCTIONAL SERVICE PROVIDERS MARKET, BY TYPE, 2019–2030 (USD MILLION)

TABLE 82 MIDDLE EAST: FUNCTIONAL SERVICE PROVIDERS MARKET, BY STAGE, 2019–2030 (USD MILLION)

TABLE 83 MIDDLE EAST: FUNCTIONAL SERVICE PROVIDERS MARKET, BY APPLICATION, 2019–2030 (USD MILLION)

TABLE 84 AFRICA: FUNCTIONAL SERVICE PROVIDERS MARKET, BY TYPE, 2019–2030 (USD MILLION)

TABLE 85 AFRICA: FUNCTIONAL SERVICE PROVIDERS MARKET, BY STAGE, 2019–2030 (USD MILLION)

TABLE 86 AFRICA: FUNCTIONAL SERVICE PROVIDERS MARKET, BY APPLICATION, 2019–2030 (USD MILLION)

TABLE 87 MAJOR PLAYERS IN THE GLOBAL FUNCTIONAL SERVICE PROVIDERS MARKET

TABLE 88 MOST ACTIVE PLAYERS IN THE GLOBAL FUNCTIONAL SERVICE PROVIDERS MARKET

TABLE 89 PRODUCT LAUNCHES

TABLE 90 PARTNERSHIPS

TABLE 91 ACQUISITIONS

TABLE 92 IQVIA INC.: SOLUTIONS/SERVICES OFFERED

TABLE 93 IQVIA INC.: KEY DEVELOPMENTS

TABLE 94 LABORATORY CORPORATION OF AMERICA HOLDINGS: PRODUCTS/SERVICES OFFERED

TABLE 95 LABORATORY CORPORATION OF AMERICA HOLDINGS: KEY DEVELOPMENTS

TABLE 96 ICON PLC: PRODUCTS/SERVICES OFFERED

TABLE 97 KPS LIFE, LLC: PRODUCTS/SERVICES OFFERED

TABLE 98 WUXI APPTEC CO., LTD.: SOLUTIONS/SERVICES OFFERED

TABLE 99 WUXI APPTEC CO., LTD.: KEY DEVELOPMENTS

TABLE 100 PPD INC.: SOLUTIONS/SERVICES OFFERED

TABLE 101 PAREXEL INTERNATIONAL CORPORATION: PRODUCTS/SERVICES OFFERED

TABLE 102 PAREXEL INTERNATIONAL CORPORATION: KEY DEVELOPMENTS

TABLE 103 QUANTICATE INTERNATIONAL LIMITED: PRODUCTS/SERVICES OFFERED

TABLE 104 QUANTICATE INTERNATIONAL LIMITED: KEY DEVELOPMENTS

TABLE 105 BIOPOINT INC.: PRODUCTS/SERVICES OFFERED

TABLE 106 RHO, INC.: PRODUCTS/SERVICES OFFERED

TABLE 107 RHO, INC.: KEY DEVELOPMENTS

ページTOPに戻る

Table of Contents
List of Tables/Graphs

Summary

Global Functional Service Providers Market Research Report - Forecast to 2030

Market Overview
The Functional Service Providers (FSP) Market is anticipated to register a healthy CAGR of 7.49% during the review period. This market is being driven by a few variables, including expanding Research and development speculations, the rising number of clinical preliminaries, and the ascent of FSP rethinking in drug improvement.
Rising Research and development ventures, particularly in the biopharmaceutical and biotechnology enterprises, have made a requirement for functional service providers (FSPs) in the worldwide market. Research showed that the utilization of FSPs by huge biopharmaceutical organizations is developing at a pace of over 13% yearly. These service providers offer staff to biopharmaceutical and biotechnology organizations for their exploration and improvement projects. They give exceptionally qualified research partners, information administrators, concentrate on organizers, clinical screens, and other related staff backing to these organizations. Biopharmaceutical and biotechnology organizations are centered around constant exploration and are chipping away at creating and embracing new advances and cycles.
Furthermore, FSPs offer arrangements like preliminary administration, clinical observing, information the board, measurable programming, biostatistics, clinical composition, lifecycle security, and administrative undertakings. The tedious and costly nature of clinical preliminaries and the issues brought about by the high responsibility bring about the rising fame of FSPs. These providers save the organization time and lessen functional expenses.
Market Segmentation
The worldwide functional service supplier market is divided in terms of type into incorporates clinical checking, clinical composition, information the board, pharmacovigilance, biostatistics/programming, administrative undertakings, and others.

In view of stage, worldwide functional service supplier market is classified into clinical turn of events and post endorsement. In view of application, the worldwide market is grouped into biopharma organizations, biotech organizations, clinical gadget organizations, and examination focuses and scholarly establishments.
Regional Insights
The North America functional service providers market represented the biggest market with a portion of roughly 41% in 2022, because of the created medical care foundation, countless clinical preliminaries, and the presence of significant vital participants in the district like IQVIA (US), Parexel (US), and Labcorp Medication Improvement (US). As per Wellbeing Canada, the power that approves clinical preliminaries in Canada, there are around 900 clinical preliminaries enlisted in Canada consistently.
Europe functional service supplier market represented the second-biggest piece of the pie because of innovation progressions, expanding medical care use, and expanding pervasiveness of ongoing sicknesses.
The Asia-Pacific functional service providers market is supposed to be the quickest developing from 2023 to 2032 attributable to high understanding populace, decreased expenses of directing preliminaries, and great administrative arrangements. Besides, central participants working in the Functional Service Providers (FSP) Market are effectively venturing into Asia-Pacific district.
Major Players
The key Companies in the Functional Service Providers Market are Parexel International Corporation (US), IQVIA, Inc. (US), Quanticate International Limited (UK), KPS Life, LLC (US), Rho, Inc. (US), Laboratory Corporation of America Holdings (US), BioPoint Inc. (US), Icon Plc (Ireland), Wuxi Apptec co., Ltd. (China), and PPD Inc. (US).

ページTOPに戻る

List of Tables/Graphs

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（医療）の最新刊レポート

Market Research Future社の医療分野での最新刊レポート

本レポートと同じKEY WORD（）の最新刊レポート

本レポートと同じKEY WORDの最新刊レポートはありません。

よくあるご質問

Market Research Future社はどのような調査会社ですか?

マーケットリサーチフューチャー（Market Research Future）は世界市場を幅広く調査し、主要分野、地域、国レベルの調査レポートを出版しています。下記分野については、分野毎に専... もっと見る

調査レポートの納品までの日数はどの程度ですか?

在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。

注文の手続きはどのようになっていますか?

1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。

お支払方法の方法はどのようになっていますか?

納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。

データリソース社はどのような会社ですか?

当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。

機能サービスプロバイダの世界市場調査レポート-2030年までの予測

サマリー

目次

図表リスト

Summary

Table of Contents

List of Tables/Graphs

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

本レポートと同分野（医療）の最新刊レポート

Market Research Future社の医療分野での最新刊レポート

本レポートと同じKEY WORD（）の最新刊レポート

よくあるご質問

Market Research Future社はどのような調査会社ですか?

調査レポートの納品までの日数はどの程度ですか?

注文の手続きはどのようになっていますか?

お支払方法の方法はどのようになっていますか?

データリソース社はどのような会社ですか?